logo

For the Inventor, By the Inventor

Irvine, CA, United States of America

Yu-An Chang

This inventor holds 6 USPTO granted patents. Top assignees: Xepmed, Inc., Other. Active years: 2002-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu-An Chang. Retrieved from https://idiyas.com/inventor/yu-an-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 16.7

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 92(Granted Patents)


Company Filing History:

goldMedal4 out of 4 
 
Xepmed, Inc.
 patents
silverMedal2 out of 834,513 
Other
 patents

Years Active: 2002-2008

Loading Chart...
6 patents (USPTO):Explore Patents
1. 7470245 - Extracorporeal pathogen reduction system (2008-12-30),
2. 7314460 - Extracorporeal pathogen reduction system (2008-01-01),
3. 6969367 - Extracorporeal pathogen reduction system (2005-11-29),
4. 6960178 - Apparatus for enhanced plasmapheresis and methods thereof (2005-11-01),
5. 6613507 - Boraadamantane compounds for the treatment of pathogenic viruses and other medical applications (2003-09-02),
6. 6423023 - Method and apparatus for enhanced plasmapheresis (2002-07-23),

Title: Yu-An Chang: Innovator in Pathogen Reduction Technology

Introduction

Yu-An Chang is a prominent inventor based in Irvine, CA, known for his significant contributions to the field of medical technology. With a total of six patents to his name, Chang has focused on developing innovative solutions for treating virus-infected or pathogen-loaded human blood components.

Latest Patents

Among his latest patents is the "Extracorporeal Pathogen Reduction System." This invention relates to an apparatus system and methods for the treatment of virus-infected or pathogen-loaded human blood components. The system comprises a separation apparatus and treatment apparatus designed to inactivate pathogens in an extracorporeal blood system. This technology aims to enhance the safety and efficacy of blood transfusions and other medical procedures involving human blood.

Career Highlights

Throughout his career, Yu-An Chang has worked with various companies, including Xepmed, Inc. His work has been instrumental in advancing medical technologies that address critical health challenges. His innovative approach and dedication to research have positioned him as a key figure in the field of pathogen reduction.

Collaborations

Chang has collaborated with notable professionals in his field, including Hosheng Tu and Hun-Chi Lin. These collaborations have contributed to the development of cutting-edge technologies that improve patient outcomes.

Conclusion

Yu-An Chang's work in pathogen reduction technology exemplifies the impact of innovation in healthcare. His patents and collaborations reflect a commitment to enhancing medical safety and efficacy. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…